ArticleMetabolomics : Official journal of the Metabolomic Society2025
Identification of an extraction protocol from dried blood spots for untargeted metabolomics: application to phenylketonuria.
Article in Metabolomics : Official journal of the Metabolomic Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimPhenylketonuria is an inherited metabolic disorder characterized by a deficiency in phenylalanine hydroxylase. However, the impact of this deficit on the patient's overall metabolism is not fully known. Studying this pathology through untargeted metabolomics requires to determine a method for metabolites extraction, here applied to Dried Blood Spot (DBS), a matrix offering several practical advantages. METHODOLOGY: The DBS of 30 phenylketonuric patients and 30 healthy controls were used for the study. Following a literature review, different extraction protocols and solvents were investigated, with or without an evaporation step, and compared to identify the most appropriate protocol to extract metabolites from the DBS for metabolomics analysis of phenylketonuria by LC-MS/MS, then applied to the patients and controls to validate its application to phenylketonuria.
resultsThe most promising extraction method is a gentle agitation overnight at 4 °C, with an evaporation step, and an extraction solvent composed by 80%/20% acetonitrile and water. This method extracted 2 to 6 times more metabolites than other protocols tested with a better extraction of amino acids and derivatives. This protocol enabled us to identify metabolic pathways that were disrupted in phenylketonuric patients, as well as differences in metabolite abundance between the different cohorts. Metabolic profiles differed both between patients and controls, and between patients according to their phenylalanine concentration. These differences were independent of the amino acid supplementation in some patients.
conclusionThe results obtained on the phenylketonuria patients cohort compared to controls, validated the extraction protocol for studying the systemic metabolic impact of phenylketonuria.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.